Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.931 EUR | -0.21% | +0.11% | -14.43% |
Apr. 30 | Sweden’s Competition Watchdog Prohibits Oriola's Dose Dispensing Unit Sale | MT |
Apr. 29 | ApotekstjÄNst Sverige Ab cancelled the acquisition of Svensk Dos AB. | CI |
Sales 2024 * | 1.55B 1.68B | Sales 2025 * | 1.59B 1.72B | Capitalization | 174M 189M |
---|---|---|---|---|---|
Net income 2024 * | - 0 | Net income 2025 * | 16M 17.3M | EV / Sales 2024 * | 0.11 x |
Net cash position 2024 * | 5.3M 5.73M | Net cash position 2025 * | 23.36M 25.25M | EV / Sales 2025 * | 0.09 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
10.3
x | Employees | 800 |
Yield 2024 * |
8.59% | Yield 2025 * |
9.31% | Free-Float | 70.11% |
Latest transcript on Oriola Oyj
1 day | -0.21% | ||
1 week | +0.11% | ||
Current month | +4.02% | ||
1 month | -11.67% | ||
3 months | -15.82% | ||
6 months | -9.61% | ||
Current year | -14.43% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 55 | 11-12-31 | |
Director of Finance/CFO | 54 | 22-11-30 | |
Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 58 | 22-12-31 | |
Director/Board Member | 55 | 22-12-31 | |
Harri Pärssinen
BRD | Director/Board Member | 61 | 19-01-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 10 M€ | -3.35% | - | |
0.00% | 34 M€ | +3.53% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-23 | 0.931 | -0.21% | 58,112 |
24-05-22 | 0.933 | +0.32% | 56,720 |
24-05-21 | 0.93 | -0.21% | 88,374 |
24-05-20 | 0.932 | +0.11% | 115,259 |
24-05-17 | 0.931 | +1.20% | 94,729 |
Delayed Quote Nasdaq Helsinki, May 23, 2024 at 11:29 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.43% | 190M | |
+20.53% | 72.45B | |
-4.71% | 23.46B | |
+4.89% | 8.59B | |
+7.11% | 8.35B | |
-23.73% | 7.88B | |
+13.92% | 5.21B | |
-0.59% | 4.11B | |
+7.85% | 4.09B | |
+20.65% | 3.6B |
- Stock Market
- Equities
- OKDBV Stock